James Carmichael
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 13
- PARP inhibition in cancer therapy 12
- Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment 8
- Cancer Research top 0.5%
- Molecular Biology top 0.5%
- Cancer therapeutics and mechanisms 8
- DNA Repair Mechanisms 5
- Genetics top 0.5%
- BRCA gene mutations in cancer 10
-
- Nausea and vomiting management 7
-
- Pharmacogenetics and Drug Metabolism 5
- Co-authors
- William DeGraffJohn D. MinnaAdi F. GazdarJames B. MitchellAndrew TuttMichael FriedländerStan B. KayeUrsula A. Matulonis
- Journals
- Journal of Clinical Oncology (10 papers)International Journal of Radiation Oncology*Biology*Physics (8 papers)Cancer Chemotherapy and Pharmacology (6 papers)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
James Carmichael
70 papers receiving 16.2k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Oncology 10.2k
- Reproductive Medicine 2.6k
- Cancer Research 2.5k
- Molecular Biology 8.6k
- Genetics 3.0k
Countries citing papers authored by James Carmichael
This map shows the geographic impact of James Carmichael's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Carmichael with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Carmichael more than expected).
Fields of papers citing papers by James Carmichael
This network shows the impact of papers produced by James Carmichael. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Carmichael. The network helps show where James Carmichael may publish in the future.
Co-authorship network
The 25 scholars most cited alongside James Carmichael, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 18 | |
| 2 | 2011 | 378 | |
| 3 | 2011 | 25 | |
| 4 | Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Intervalbreakdown → | 2010 | 745 |
| 5 | Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trialbreakdown → | 2010 | 1286 |
| 6 | Abstract #5494: Pre-clinical evaluation of single-agent activity of the PARP inhibitor olaparib (AZD2281) in homologous recombination deficient triple-negative breast cancer | 2009 | 1 |
| 7 | Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriersbreakdown → | 2009 | 2698 |
| 8 | 2008 | 164 | |
| 9 | 2004 | 114 | |
| 10 | 2004 | 8 | |
| 11 | 2004 | 17 | |
| 12 | 2003 | 47 | |
| 13 | 1997 | 33 | |
| 14 | 1996 | 8 | |
| 15 | 1993 | 14 | |
| 16 | 1992 | 47 | |
| 17 | 1991 | 17 | |
| 18 | 1989 | 116 | |
| 19 | 1989 | 13 | |
| 20 | 1986 | 28 |
About James Carmichael
James Carmichael is a scholar working on Oncology, Reproductive Medicine, Toxicology, Pharmacology and Dermatology, having authored 72 papers that have together received 16.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (13 papers), PARP inhibition in cancer therapy (12 papers), BRCA gene mutations in cancer (10 papers), Cancer therapeutics and mechanisms (8 papers), Ovarian cancer diagnosis and treatment (8 papers), Nausea and vomiting management (7 papers), DNA Repair Mechanisms (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Oncology (10.2k citations), Reproductive Medicine (2.6k citations), Cancer Research (2.5k citations), Molecular Biology (8.6k citations) and Genetics (3.0k citations). James Carmichael has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include William DeGraff, John D. Minna, Adi F. Gazdar, James B. Mitchell, Andrew Tutt, Michael Friedländer, Stan B. Kaye, Ursula A. Matulonis, Timothy A. Yap and Mark Wickens. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Cancer Chemotherapy and Pharmacology, Carcinogenesis and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.